Skip to main content
LIWANLI logo

LIWANLI — Investor Relations & Filings

Ticker · 3054 ISIN · TW0003054003 TW Wholesale and retail trade
Open in API
Filings indexed 1,630 across all filing types
Latest filing 2025-09-09 Fund Information / Fact…
Country TW Taiwan
Listing TW 3054

About LIWANLI

https://www.liwanli.com.tw

Liwanli Innovation Co., Ltd. is a technology-driven enterprise that transitioned from its origins in mobile multimedia and storage solutions into the biotechnology and healthcare sectors. Originally established in 1991, the company underwent a strategic rebranding in 2015 to focus on the research, development, and distribution of health supplements and nutritional products. Its core operations involve the creation of patented formulas and the application of innovative R&D techniques to meet consumer wellness needs. The company leverages extensive industry-university collaborations and maintains advanced laboratory facilities to ensure the scientific integrity of its product offerings. In addition to its primary focus on biotechnology and health products, the company continues to engage in the sale of electronic components and consumer electronics, emphasizing a philosophy of precision and nutritional excellence.

Recent filings

Filing Released Lang Actions
114年8月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a revenue summary report from a listed company, showing monthly and cumulative net operating revenue figures with percentage changes and explanations. It is a brief financial data summary without detailed financial statements or comprehensive analysis. The length is short (781 characters), and it does not contain full financial reports or management discussion. This fits the definition of a Fund Information / Factsheet (FS), which is a brief summary of key company financials and market info.
2025-09-09 Chinese
114年08月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings and changes in shareholdings by insiders such as directors, chairpersons, general managers, and other key personnel. It includes specific data on stock types, quantities held at different times, increases and decreases in holdings, and notes on identities and roles. There is no indication of financial statements, earnings data, or management discussion. The content is focused on insider share transactions and holdings disclosures. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades). The document length is sufficient and the content is substantive insider shareholding data, not a mere announcement or certification. Therefore, the correct classification is DIRS with high confidence.
2025-09-04 Chinese
114年08月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabular disclosure of shareholdings by company insiders, including directors, independent directors, and senior management, with specific numbers of shares held and pledged. It includes notes about the absence of certain managerial positions and clarifies the calculation methods for shareholding percentages. There is no indication of financial statements, earnings data, or report publication announcements. The content focuses on insider shareholdings and related disclosures, which aligns with the definition of Director's Dealing (DIRS) filings, which report personal share transactions or holdings by company directors and executives. The document length is 2675 characters, which is relatively short but contains substantive insider shareholding data rather than just an announcement. Therefore, the best classification is DIRS with high confidence.
2025-09-04 Chinese
114年第2季海外子公司投資
Regulatory Filings Classification · 95% confidence The document is a financial disclosure related to investment in overseas subsidiaries, showing investment amounts, holding percentages, and recognized investment gains or losses for a specific quarter (114年2季, which corresponds to the second quarter of the 114th year in the Taiwanese calendar). The content is tabular and concise, focusing on investment details rather than a full financial report or narrative. The document length is only 646 characters, which is quite short and does not contain comprehensive financial statements or management discussion. It appears to be a regulatory disclosure or filing related to investment holdings rather than a full annual or interim report. Given the nature and length, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2025-08-08 Chinese
114年第2季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts and related financial figures concerning investments in mainland China by a Taiwanese listed company. It includes specific financial data such as capital amounts, investment methods, cumulative investment amounts, recognized investment gains or losses, and regulatory approval limits. The document is relatively short (1295 characters) and focuses on investment details rather than a full financial report or announcement. It does not appear to be an announcement of a report publication, nor is it a certification or a brief summary. The content aligns with regulatory disclosure requirements for cross-border investments, which typically fall under general regulatory filings. There is no indication that this is an annual report, interim report, earnings release, or any other specific report type. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2025-08-08 Chinese
114年7月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, providing information about the absence of fund loans and endorsement guarantees for the current and previous months, including details about subsidiaries and mainland China exposure. The content is concise, factual, and regulatory in nature, without detailed financial statements or analysis. It does not represent a full financial report but rather a regulatory compliance disclosure. Given the short length (602 characters) and the nature of the content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-08-08 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.